NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes

Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment

Volumn 25, Issue 1, 2008, Pages 76-87

  Afriyie Gyawu, E ^a   Ankrah, N A ^b   Huebner, H J ^a   Ofosuhene, M ^b   Kumi, J ^b   Johnson, N M ^a   Tang, L ^c   Xu, L ^c   Jolly, P E ^d   Ellis, W O ^e   Ofori Adjei, D ^b   Williams, J H ^f   Wang, J S ^c   Phillips, T D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b University of Ghana   (Ghana)

^c TEXAS TECH UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^f UNIVERSITY OF GEORGIA   (United States)

Author keywords

Aflatoxin; Clinical outcomes; Enterosorbent; NovaSil clay; Safety

Indexed keywords

AFLATOXIN B1; ALANINE AMINOTRANSFERASE; ALBUMIN; ANTIDOTE; BILIRUBIN; CALCIUM MONTMORILLONITE; CREATININE; NITROGEN; NOVASIL; PLACEBO; SODIUM; UNCLASSIFIED DRUG; UREA;

ABDOMINAL DISCOMFORT; ADULT; AFLATOXICOSIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; BLOATING; BLOOD ANALYSIS; CLAY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FLATULENCE; GHANA; HEALTH STATUS; HEARTBURN; HIGH RISK POPULATION; HUMAN; INDIGESTION; INSOMNIA; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SODIUM BLOOD LEVEL; SYMPTOM; TOXIN ANALYSIS; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VOLUNTEER; VOMITING;

ADULT; AFLATOXINS; ALUMINUM SILICATES; ANTIDOTES; DOUBLE-BLIND METHOD; ENTEROSORPTION; FEMALE; FOOD; FOOD ADDITIVES; GHANA; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 36749022875     PISSN: 19440049     EISSN: 19440057     Source Type: Journal    
DOI: 10.1080/02652030701458105     Document Type: Article

References (66)

1. Adu, SV, and Mensah-Ansah, JA. 1995. “ Soils of the Afram Basin:Ashanti and Eastern Regions, Ghana. Soil Research Institute ”. In Council for Scientific & Industrial Research, 17–53. Accra, Ghana:Advent Press. Memoir No.12
2. Afriyie-Gyawu, E, Mackie, J, Dash, B, Wiles, MC, Taylor, J, Huebner, HJ, Tang, L, Guan, H, Wang, J-S, and Phillips, TD. 2005. Long-term toxicological evaluation of NovaSil clay in the diet of Sprague–Dawley rats. Food Additives and Contaminants, 22:259–269.
3. Awuah, RT, and Kpodo, KA. 1996. High incidence of Aspergillus flavus and aflatoxins in stored groundnuts in Ghana and the use of microbial assay to assess the inhibitory effects of plant extracts on aflatoxin synthesis. Mycopathologia, 134:109–114.
4. Azziz-Baumgartner, E, Lindblade, K, Gieseker, K, Rogers, HS, Kieszak, S, Njapau, H, Schleicher, R, McCoy, LF, Misore, A, DeCock, K. 2005. Case–control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environmental Health Perspectives, 113 (12):1779–1783.
5. Busby, WF, and Wogan, GN. 1984. “ Aflatoxins ”. In Chemical Carcinogens, Edited by:Seale, CD. 945–1136. Washington, DC:American Chemical Society.
6. CAST (Council for Agricultural Science and Technology). 1989. “ Mycotoxins:Economic and Health Risks ”. In Task Force Report No. 116, Edited by:Niyo, K. 1–91. Ames, IA:Council for Agricultural Science and Technology.
7. CAST (Council for Agricultural Science and Technology). 2003. “ Mycotoxins:Risks in plant, animal, and human systems ”. In Task Force Report No. 139, 13–85. Ames, IA:Council for Agricultural Science and Technology.
8. Centers for Disease Control and Prevention (CDC). 2004. Outbreak of aflatoxin poisoning–Eastern and Central Provinces, Kenya. Morbidity and Mortality Weekly Report, 53:790–793.
9. Chi, WJ, Doong, SL, Lin-Shiau, SY, Boone, CW, Kelloff, GJ, and Lin, JK. 1998. Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein. Carcinogenesis, 19:2133–2138.
10. Dashwood, R, Negishi, T, Hayatsu, H, Breinholt, V, Hendricks, J, and Bailey, G. 1998. Chemopreventive properties of chlorophylls towards aflatoxin B1:A review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutation Research, 399:245–253.
11. District Health Directorate. 2005. Ejura/Sekyedumase, Ashanti Region 1–2. Ghana
12. Dragsted, LO, Strube, M, and Larsen, JC. 1993. Cancer-protective factors in fruits and vegetables:Biochemical and biological background. Pharmacological Toxicology, 72:116–135.
13. Egner, PA, Wang, J-B, Zhu, Y-R, Zhang, B-C, Wu, Y, Zhang, Q-N, Qian, G-S, Kuang, S-Y, Gange, SJ, Jacobson, LP. 2001. Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer. Proceedings of the National Academy of Sciences USA, 98:14601–14606.
14. Flaherty, JE, and Payne, GA. 1997. Overexpression of aflR leads to upregulation of pathway gene transcription and increased aflatoxin production in Aspergillus flavus. Applied and Environmental Microbiology, 63:3995–4000.
15. Fujiki, H, Suganuma, M, Imai, K, and Nakachi, K. 2002. Green tea:Cancer preventive beverage and/or drug. Cancer Letter, 188:9–13.
16. George-Gay, B, and Parker, K. 2003. Understanding the complete blood count with differential. Journal of PeriAnesthesia Nursing, 18:96–117.
17. Gong, YY, Cardwell, K, Hounsa, A, Egal, S, Turner, PC, Hall, AJ, and Wild, CP. 2002. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo:Cross sectional study. British Medical Journal, 325:20–21.
18. Gong, YY, Egal, S, Hounsa, A, Turner, PC, Hall, AJ, Cardwell, KF, and Wild, CP. 2003. Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa:The critical role of weaning. International Journal of Epidemiology, 32:556–562.
19. Goodnough, LT, Brecher, ME, and Katner, MH. 1999. Transfusion medicine:Blood transfusion. New England Journal of Medicine, 340:438–447.
20. 1 on HSCAS clay. Journal of Agriculture and Food Chemistry, 46:599–605.
21. Gupta, RA, and DuBois, RN. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Reviews of Cancer, 1:11–21.
22. Harvey, RB, Kubena, LF, Phillips, TD, Corrier, DE, Elissalde, MH, and Huff, WE. 1991a. Diminution of aflatoxin toxicity to growing lambs by dietary supplementation with hydrated sodium calcium aluminosilicate. American Journal of Veterinary Research, 52:152–156.
23. 1 residues in milk by addition of hydrated sodium calcium aluminosilicate to aflatoxin-contaminated diets of dairy cows. American Journal of Veterinary Research, 52:1556–1559.
24. Hayatsu, H, Arimoto, S, and Negishi, T. 1988. Dietary inhibitors of mutagenesis and Carcinogenesis. Mutation Research, 202:429–446.
25. Henry, SH, Bosch, FX, and Bowers, JC. 2002. Aflatoxins, hepatitis, and worldwide liver cancer risks. Advances in Experimental Medicine and Biology, 504:229–233.
26. Hinton, DM, Myers, MJ, Raybourne, RA, Francke-Carroll, S, Sotomayor, RE, Shaddock, J, Warbritton, A, and Chou, MW. 2003. Immunotoxicity of aflatoxins in rats:Effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study. Toxicological Sciences, 73:362–377.
27. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene, Vol. 82, 171–274. Lyon, France:International Agency for Research on Cancer.
28. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. 1993. Some naturally occurring substances:Food items and constituents, heterocyclic aromatic amines and mycotoxins, Vol. 51, 207–271. Lyon, France:International Agency for Research on Cancer.
29. JECFA (Joint FAO/WHO Expert Committee on Food Additives). 1998. “ Aflatoxins:Safety evaluation of certain food additives and contaminants. In:The Forty-Ninth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. WHO Food Additive Series no. 40 ”. In International Program on Chemical Safety, 359–468. Geneva:World Health Organization.
30. Jensen, E, and Bolger, PM. 2001. Exposure assessment of dioxins/furans consumed in dairy foods and fish. Food Additives and Contaminants, 18:395–403.
31. Jespersen, L, Halm, M, Kpodo, K, and Jacobsen, M. 1994. Significance of yeasts and molds occurring in maize dough fermentation for “kenkey” production. International Journal of Food Microbiology, 24:239–248.
32. 1 albumin adduct levels and cellular immune status in Ghanaians. International Immunology, 17:807–814.
33. Jolly, PE, Jiang, Y, Ellis, W, Awuah, R, Nnedu, O, Phillips, TD, Wang, JS, Afriyie-Gyawu, E, Tang, L, Person, S. 2006. Determinants of aflatoxin levels in Ghanaians:Sociodemographic factors, knowledge of aflatoxin and food handling and consumption practices. International Journal of Hygiene and Environmental Health, 209:345–358.
34. Kensler, TW, Groopman, JD, Sutter, TR, Curphey, TJ, and Roebuck, BD. 1999. Development of cancer chemopreventive agents:Oltipraz as a paradigm. Chemical Research in Toxicology, 12:113–126.
35. 1 and hepatitis B virus in hepatocarcinogenesis. Liver International, 23:405–409.
36. Klaunig, J, and Kamendulis, L. 1999. Mechanisms of cancer chemoprevention in hepatic carcinogenesis:Modulation of focal lesion growth in mice. Toxicological Science, 52:101–106.
37. Kubena, LF, Huff, WE, Harvey, RB, Yersin, AG, Elissalde, MH, Witzel, DA, Giroir, LE, and Phillips, TD. 1991. Effects of hydrated sodium calcium aluminosilicate on growing turkey poults during aflatoxicosis. Poultry Science, 70:1823–1830.
38. Kurtzman, CP, Horn, BW, and Hesseltine, CW. 1987. Aspergillus nominus:A new aflatoxin-producing species related to Aspergillus flavus and Aspergillus tamari. Antonie van Leeuwenhoek, 53:147
39. Lewis, L, Onsongo, M, Njapau, H, Rogers, HS, Luber, G, Kieszak, S, Nyamongo, J, Backer, L, Dahiye, AM, Misore, A. 2005. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in Eastern and Central Kenya. Environmental Health Perspectives, 113:1763–1767.
40. Lindermann, MD, Blodgett, DJ, Kornegay, ET, and Schurig, GG. 1993. Potential ameliorators of aflatoxicosis in weanling/growing swine. Journal of Animal Science, 71:171–178.
41. Mayura, K, Abdel-Wahhab, MA, McKenzie, KS, Sarr, AB, Edwards, JF, Naguib, K, and Phillips, TD. 1998. Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents:Potential hidden risks. Toxicological Sciences, 41:175–182.
42. McAlpin, CE, Wicklow, DT, and Horn, BW. 2002. DNA fingerprinting analysis of vegetative compatibility groups in Aspergillus flavus from a peanut field in Georgia. Plant Diseases, 86:254–258.
43. Nakachi, K, Matsuyama, S, Miyake, S, Suganuma, M, and Imai, K. 2000. Preventive effects of drinking green tea on cancer and cardiovascular disease:Epidemiological evidence for multiple targeting prevention. BioFactors, 13:49–54.
44. Ngindu, A, Kenya, PR, Ocheng, DM, Omonde, TN, Ngare, W, Gatei, D, Johnson, BK, Ngira, JA, Nandwa, H, Jansen, AJ. 1982. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet, 1:1346–1348.
45. Phillips, TD, Kubena, LF, Harvey, RB, Taylor, DR, and Heidelbaugh, ND. 1988. Hydrated sodium calcium aluminosilicate:A high affinity sorbent for aflatoxin. Poultry Science, 67:243–247.
46. Phillips, TD, Lemke, SL, and Grant, PG. 2002. “ Characterization of clay-based enterosorbents for the prevention of aflatoxicosis ”. In Advances in Experimental Medicine and Biology:Mycotoxins and Food Safety, Edited by:DeVries, JW, Trucksess, MW, and Jackson, LS. Vol. 504, 157–171. New York:Kluwer Academic/Plenum Publishers.
47. Phillips, TD. 1999. Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicological Sciences, 52:118–126.
48. Pimpukdee, K, Kubena, LF, Bailey, CA, Huebner, HJ, Afriyie-Gyawu, E, and Phillips, TD. 2004. Aflatoxin-induced toxicity and depletion of hepatic vitamin A in young broiler chicks:Protection of chicks in the presence of low levels of NovaSil PLUS in the diet. Poultry Science, 83:737–744.
49. Roebuck, BD, and Maxuitenko, YY. 1994. “ Biochemical mechanisms and biological implications of the toxicity of aflatoxins as related to aflatoxin carcinogenesis ”. In The Toxicology of Aflatoxins, Edited by:Eaton, DL, and Groopman, JD. 27–43. San Diego, CA:Academic Press.
50. Shephard, G. 2003. Aflatoxin and food safety:Recent African perspectives. Journal of Toxicology, 22:267–286.
51. 1 in newborn and partially hepatectomized mice. Toxicology Letters, 148:1–9.
52. 1 residue in dairy goat milk and effects on milk production and components. Journal Animal Science, 72:677–682.
53. Sporn, MB, and Suh, N. 2002. Chemoprevention:An essential approach to controlling cancer. Nature Reviews of Cancer, 2:537–543.
54. Statin, JR, Rose, M, Wright, C, Packer, I, and Gilbert, J. 1990. Surveillance of British foods for PCDDs and PCDFs. Chemosphere, 20:793–798.
55. Turner, PC, Moore, SE, Hall, AJ, Prentice, AM, and Wild, CP. 2003. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environmental Health Perspective, 111:217–220.
56. US National Institute of Health (USNIH). 2006. Guidelines for clinical trials:Developed by the National library of Medicine, a service of the USNIH. Available:http://clinicaltrials.gov/ct/info/whatis. Accessed 18 December 2006.
57. Van den Berg, M, Birnbaum, L, Bosveld, AT, Brunstrom, B, Cook, P, Feeley, M, Giesy, JP, Hanberg, A, Hasegawa, R, Kennedy, SW. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environmental Health Perspective, 106:775–792.
58. Wang, J-S, and Groopman, JD. 1999. DNA damage by mycotoxins. Mutation Research, 424:167–181.
59. Wang, J-S, Luo, H, Billam, M, Wang, Z, Guan, H, Tang, L, Goldston, T, Afriyie-Gyawu, E, Lovett, C, Griswold, J. 2005. Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans. Food Additives and Contaminants, 22:270–279.
60. Wang, J-S, Qian, GS, Zarba, A, He, X, Zhu, YR, Zhang, BC, Jacobson, L, Gange, SJ, Munoz, A, Kensler, TW. 1996. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiology Biomarkers and Prevention, 5:253–261.
61. Wang, J-S, Shen, X, He, X, Zhu, Y-R, Zhang, B-C, Wang, J-B, Qian, G-S, Kuang, S-Y, Zarba, A, Egner, PA. 1999. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by Oltipraz in residents of Qidong, People's Republic of China. Journal of the National Cancer Institute, 91:347–354.
62. Wild, CP, and Hall, AJ. 2000. Primary prevention of hepatocellular carcinoma in developing countries. Mutation Research, 462:381–393.
63. Wild, CP, Hudson, GJ, Sabbioni, G, Chapot, B, Hall, AJ, Wogan, GN, Whittle, H, Montesano, R, and Groopman, JD. 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiology Biomarkers and Prevention, 1:229–234.
64. Wiles, MC, Huebner, HJ, Afriyie-Gyawu, E, Taylor, RJ, Bratton, GR, and Phillips, TD. 2004. Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. Journal Toxicology and Environmental Health A, 67:863–874.
65. Williams, JH, Phillips, TD, Jolly, PE, Stiles, JK, Jolly, CM, and Aggarwal, D. 2004. Human aflatoxicosis in developing countries:A review of toxicology, exposure, potential health consequences, and interventions. American Journal of Clinical Nutrition, 80:1106–1122.
66. Wogan, GN. 1992. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Research (Suppl), 52:2114s–2118s.